Sort
82,697 grants matching “vaccine development”
Malaria Vaccines: AMA1-C2/ALHYDROGEL + CPG 7909
$1,028,315Louis Miller · Niaid Extramural Activities · Z01 · FY2007 · AI
Malaria Vaccines: Pfs25-Pfs25/ALHYDROGEL
$1,028,315Louis Miller · Niaid Extramural Activities · Z01 · FY2007 · AI
Malaria Vaccines: CSP-rEPA/ALHYDROGEL
$1,028,315Louis Miller · Niaid Extramural Activities · Z01 · FY2007 · AI
Immune reconstitution following autologous and allogeneic stem cell transplant
$1,028,281Francis Flomerfelt · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
UCSF HIV Clinical Trials Unit
$1,028,280Diane V Havlir · University Of California, San Francisco · U01 · FY2008 · AI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls
$1,028,088Angela Diaz · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · AI
Development of Novel Therapeutic Agents for Norovirus Infection
$1,027,980Kyeong-Ok Chang · Kansas State University · U01 · FY2010 · AI
CHARACTERIZATION OF TUMOR ANTIGENS THAT ELICIT HUMORAL IMMUNE RESPONSES IN MAN
$1,027,837John Wayne Cancer Institute · P01 · FY2000 · CA
CLINICAL INVESTIGATION OF ACTIVE SPECIFIC IMMUNOTHERAPY OF MALIGNANT MELANOMA
$1,027,837John Wayne Cancer Institute · P01 · FY2000 · CA
Acute Hepatitis C Infection in Young Injectors
$1,027,825Kimberly Page · University Of California, San Francisco · R01 · FY2012 · DA
Novel adjuvants for biodefense vaccines
$1,027,810Tulane University Of Louisiana · U01 · FY2003 · AI
Coxiella burnetii immunobiology, host-pathogen modeling, and countermeasure development
$1,027,718Carrie Mae Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
An adjuvant that promotes TH1/TH17 and CD8 T cells in a tuberculosis vaccine
$1,027,582Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · AI
Malaria Parasite Ligands And Host Cell Receptors
$1,027,546Louis Miller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
PROJECT 2:Structural studies of SOSIP trimers
$1,027,402Ian A Wilson · Weill Medical Coll Of Cornell Univ · P01 · FY2020 · AI
Ethical, Legal and Social Issues for Precision Medicine and Infectious Disease
$1,027,331Gail Geller · Johns Hopkins University · RM1 · FY2017 · HG
A dual vaccine strategy against filovirus infection
$1,027,065Richard W Compans · Emory University · R01 · FY2014 · AI
HIV pathogenesis, prevention and treatment in the Andes
$1,026,977Asociacion Civil Impacta Salud Y Educacn · U19 · FY2005 · AI
Recombinant Attenuated Bacterial Vaccines Against Biodefense Agents
$1,026,895Roy Curtiss · Arizona State University-Tempe Campus · R01 · FY2011 · AI
Role of Innate Immune Dysregulation in the Etiology of Dementia
$1,026,477Annelise Emily Barron · Stanford University · DP1 · FY2021 · AG
The mucosal immune system: effects of aging and chronic antigenic stimulation
$1,026,461Rita Brickman Effros · University Of California Los Angeles · R01 · FY2009 · AG
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)
$1,026,345Ann R Falsey · University Of Rochester · UM1 · FY2023 · AI
Los Angeles Pediatric AIDS Clinical Trials Unit
$1,026,140University Of California Los Angeles · U01 · FY2002 · AI
Protection Against Inhalation Anthrax with Inactivated Spores
$1,026,116Donald G. Guiney · University Of California, San Diego · U01 · FY2010 · AI
Generation of Robust Resident Memory T cells in Barrier Tissues through Skin Vaccination
$1,025,901Thomas S. Kupper · Brigham And Women'S Hospital · R01 · FY2019 · AI